Taylor Andrew Lawrence 4

What Happened

• Andrew (Taylor) Lawrence, Chief Financial Officer of Orchestra BioMed (OBIO), had 3,076 shares withheld by the company to satisfy tax withholding obligations tied to vested restricted stock units (RSUs). The withholding was at $3.98 per share, for a total value of about $12,242. This was a tax-withholding disposition, not an open-market sale.

Key Details

• Transaction date and price: May 28, 2026 — 3,076 shares withheld at $3.98/share (total ≈ $12,242).
• Transaction code: F (withholding of shares to satisfy tax withholding on RSU vesting).
• Footnote: Issuer withheld shares to cover tax obligations; no shares were sold in the market as a result of the withholding (F1).
• Filing date/timeliness: Form 4 filed May 29, 2026 — appears timely (Form 4 is generally due within two business days of the transaction).
• Shares owned after transaction: Not specified in the provided filing details.

Context

• This was a routine tax-withholding action on RSU vesting (a common administrative step) rather than a discretionary sale or purchase. Such withholdings do not necessarily indicate insider sentiment about the stock; they simply cover the insider’s tax obligation on vested equity.